Steven Pieper, See Remarks at Xeris Biopharma Holdings, Inc. (XERS), sold 5,000 shares at $8.50 ($43K) on 2026-08-12, disclosed to the SEC on 2026-08-12.
Scheduled sale ($42k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| XERS | SELL | 2026-07-07 | $383K | — | Filing → |
| XERS | BUY | 2023-11-21 | $55K | — | Filing → |
| XERS | BUY | 2021-11-12 | $50K | — | Filing → |